MANCINI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 1.165
EU - Europa 624
AS - Asia 205
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.022
Nazione #
US - Stati Uniti d'America 1.163
IT - Italia 203
UA - Ucraina 118
SE - Svezia 71
CN - Cina 66
IE - Irlanda 64
DE - Germania 53
DK - Danimarca 46
TR - Turchia 46
SG - Singapore 44
FI - Finlandia 32
CI - Costa d'Avorio 26
KR - Corea 26
GB - Regno Unito 17
IN - India 14
BE - Belgio 9
GR - Grecia 4
HK - Hong Kong 4
FR - Francia 3
CA - Canada 2
IR - Iran 2
JP - Giappone 2
AT - Austria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EU - Europa 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
Totale 2.022
Città #
Chandler 170
Fairfield 120
Jacksonville 120
Ashburn 89
Dublin 64
Wilmington 55
Houston 52
New York 52
Woodbridge 46
Seattle 45
Ann Arbor 43
Boardman 38
Cambridge 33
Des Moines 31
Pianella 27
Abidjan 26
Lawrence 25
Princeton 25
San Mateo 25
Turin 25
Beijing 23
Centro 23
Porto 22
Singapore 15
Marche 9
Milan 9
San Diego 9
Los Angeles 8
Brussels 7
Helsinki 7
Cagliari 6
Hyderabad 6
Pune 6
Shanghai 6
Catania 5
Guangzhou 5
Redmond 5
Hong Kong 4
London 4
Wuhan 4
Wuxi 4
Civitanova Marche 3
Norwalk 3
Pistoia 3
Albiate 2
Ancona 2
Athens 2
Delhi 2
Markopoulo Mesogaias 2
Ningbo 2
Ottawa 2
Palermo 2
Prescot 2
Rome 2
Seoul 2
Terlizzi 2
Tolentino 2
Venice 2
Washington 2
Zibo 2
Acton 1
Agugliano 1
Auburn Hills 1
Clifton 1
Dalian 1
Fayetteville 1
Fermo 1
Fossombrone 1
Gaiole In Chianti 1
Glendale 1
Hebei 1
Hounslow 1
Izmir 1
Kagoya 1
Kilburn 1
Kish 1
Lausanne 1
Manila 1
Nürnberg 1
Olomouc 1
Pesaro 1
Pisa 1
Prineville 1
Reggio Calabria 1
Simi Valley 1
Southwark 1
Stockholm 1
Tauranga 1
Tokyo 1
Torre Del Greco 1
Tübingen 1
Vienna 1
Totale 1.371
Nome #
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? 151
Human de-differentiated adipocytes show similar properties to bone marrow derived mesenchymal stem cells 134
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 118
Glial-like differentiation potential of human mature adipocytes 106
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 99
Human bone marrow adipocytes maintain the survival and differentiation of hematopoietic stem cells 98
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 95
Plasticity of human dedifferentiated adipocytes toward endothelial cells 90
Biosafety evidence for human dedifferentiated adipocytes 87
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 85
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 85
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 75
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 74
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype 73
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. 65
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 63
Identification of different adypocytes populations within human marrow microenvironment 63
OVEREXPRESSION OF CDKN2B IS ASSOCIATED WITH REDUCED PROLIFERATIVE POTENTIAL IN MESENCHYMAL STEM CELL FROM HIGH-RISK MYELODYSPLASTIC SYNDROME 61
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 61
TREATMENT WITH AZACITIDINE REVERSES MESENCHYMAL STEM CELLS DERIVED FROM HIGH RISK MYELODYSPLASTIC PATIENTS TO A NORMAL PHENOTYPE 58
Predictive value of post-induction and post-consolidation MRD: a comparison of multiparameter flow cytometry and WT1 RT-PCR techniques in 75 acute myeloid leukemia (AML) patients 57
Mesenchymal stem cells of myelodysplastic syndromes show impaired hematopoietic support function and global DNA hypermethylation status 55
Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience. 54
Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report 53
Ruolo degli adipociti nell’emopoiesi umana 50
Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide. 48
P1045: IS JAK2V617F BUT NOT CALR AS DRIVER MUTATION ENOUGH BY ITSELF IN THE PATHOGENESIS OF UNUSUAL TYPE VENOUS THROMBOSIS IN MPN PATIENTS? 20
A rare case of aCML associated with CNS involvement and with aggressive clinical course 18
Totale 2.096
Categoria #
all - tutte 9.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.161


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020169 2 1 25 1 26 0 27 2 24 3 26 32
2020/2021464 11 42 35 1 100 75 86 12 34 14 41 13
2021/2022217 12 50 5 12 2 7 6 15 16 28 16 48
2022/2023482 37 65 32 40 25 73 2 31 100 2 58 17
2023/2024301 41 7 16 31 38 85 9 20 2 14 12 26
2024/202577 77 0 0 0 0 0 0 0 0 0 0 0
Totale 2.096